5244042025-01-012025-03-315244042025-03-315244042025-01-012025-03-31CompositionOfBoardOfDirectors15244042025-03-31CompositionOfBoardOfDirectors15244042025-01-012025-03-31CompositionOfBoardOfDirectors25244042025-03-31CompositionOfBoardOfDirectors25244042025-01-012025-03-31CompositionOfBoardOfDirectors35244042025-03-31CompositionOfBoardOfDirectors35244042025-01-012025-03-31CompositionOfBoardOfDirectors45244042025-03-31CompositionOfBoardOfDirectors45244042025-01-012025-03-31CompositionOfBoardOfDirectors55244042025-03-31CompositionOfBoardOfDirectors55244042025-01-012025-03-31CompositionOfBoardOfDirectors65244042025-03-31CompositionOfBoardOfDirectors65244042025-01-012025-03-31CompositionOfBoardOfDirectors75244042025-03-31CompositionOfBoardOfDirectors75244042025-01-012025-03-31CompositionOfBoardOfDirectors85244042025-03-31CompositionOfBoardOfDirectors85244042025-01-012025-03-31CompositionOfCommittees145244042025-03-31CompositionOfCommittees145244042025-01-012025-03-31CompositionOfCommittees155244042025-03-31CompositionOfCommittees155244042025-01-012025-03-31CompositionOfCommittees165244042025-03-31CompositionOfCommittees165244042025-01-012025-03-31CompositionOfCommittees175244042025-03-31CompositionOfCommittees175244042025-01-012025-03-31CompositionOfCommittees415244042025-03-31CompositionOfCommittees415244042025-01-012025-03-31CompositionOfCommittees425244042025-03-31CompositionOfCommittees425244042025-01-012025-03-31CompositionOfCommittees435244042025-03-31CompositionOfCommittees435244042025-01-012025-03-31CompositionOfCommittees445244042025-03-31CompositionOfCommittees445244042025-01-012025-03-31CompositionOfCommittees685244042025-03-31CompositionOfCommittees685244042025-01-012025-03-31CompositionOfCommittees695244042025-03-31CompositionOfCommittees695244042025-01-012025-03-31CompositionOfCommittees705244042025-03-31CompositionOfCommittees705244042025-01-012025-03-31CompositionOfCommittees715244042025-03-31CompositionOfCommittees715244042025-01-012025-03-31CompositionOfCommittees955244042025-03-31CompositionOfCommittees955244042025-01-012025-03-31CompositionOfCommittees965244042025-03-31CompositionOfCommittees965244042025-01-012025-03-31CompositionOfCommittees975244042025-03-31CompositionOfCommittees975244042025-01-012025-03-31CompositionOfCommittees1225244042025-03-31CompositionOfCommittees1225244042025-01-012025-03-31CompositionOfCommittees1235244042025-03-31CompositionOfCommittees1235244042025-01-012025-03-31CompositionOfCommittees1245244042025-03-31CompositionOfCommittees1245244042025-03-31MeetingOfBoardOfDirectors15244042025-01-012025-03-31MeetingOfBoardOfDirectors15244042025-03-31MeetingOfBoardOfDirectors25244042025-01-012025-03-31MeetingOfBoardOfDirectors25244042025-01-012025-03-31MeetingOfCommittees15244042025-03-31MeetingOfCommittees15244042025-01-012025-03-31MeetingOfCommittees25244042025-03-31MeetingOfCommittees25244042025-01-012025-03-31MeetingOfCommittees35244042025-03-31MeetingOfCommittees35244042025-01-012025-03-31MeetingOfCommittees45244042025-03-31MeetingOfCommittees45244042025-01-012025-03-31MeetingOfCommittees55244042025-03-31MeetingOfCommittees55244042025-01-012025-03-31MeetingOfCommittees65244042025-03-31MeetingOfCommittees65244042025-01-012025-03-31MeetingOfCommittees75244042025-03-31MeetingOfCommittees75244042024-12-315244042025-03-31OngoingTaxLitigationsOrDisputesDomain15244042025-03-31OngoingTaxLitigationsOrDisputesDomain2xbrli:pure524404MARKSANSNOTLISTEDINE750C01026MARKSANS PHARMA LIMITED2024-04-012025-03-31Yearly2025-03-31EquitytruetruefalseThere is no acquisition of shares or voting rights in any unlisted companies during the quarter under report.falseThere is no fine or penalty imposed on the Company by any regulatory authority during the quarter under report.truefalseDuring the quarter under repport, there is no loans/guarantees/comfort letters/securities given to the Promoters, Promoter Groups, Directors, KMPs or any entities controlled by them. trueTop 1000 listed entitiestruem00116OriginaltruetrueMrMARK SALDANHA00020983Executive DirectorChairperson related to PromoterCEO-MD1972-08-18falseActiveNA2005-10-062020-10-061000MrsSANDRA SALDANHA00021023Executive DirectorNot Applicable1971-12-11falseActiveNA2014-09-252023-09-251000MrVARDDHMAN VIKRAMADITYA JAIN08338573Executive DirectorNot Applicable1969-10-14falseActiveNA2019-01-242025-01-241010MrSEETHARAMA RAJU BUDDHARAJU03630668Non-Executive - Independent DirectorNot Applicable1951-10-01falseActiveNA2015-04-012020-04-012025-03-311201111Tenure CompletionMrDIGANT MAHESH PARIKH00212589Non-Executive - Independent DirectorNot Applicable1972-09-23falseActiveNA2018-03-142023-03-14851111MrABHINNA SUNDAR MOHANTY00007995Non-Executive - Independent DirectorNot Applicable1953-10-02falseActiveNA2019-07-112024-07-11681120MrsSHAILAJA VARDHAN10172764Non-Executive - Independent DirectorNot Applicable1967-04-02falseActiveNA2023-05-302023-05-30221100MrSUNNY SHARMA02267273Non-Executive - Non Independent DirectorNot Applicable1974-08-31falseActiveNA2021-08-112021-08-11442010truetruetruetruetrueAudit Committee00212589DIGANT MAHESH PARIKHNon-Executive - Independent DirectorChairperson2018-03-14Audit Committee03630668SEETHARAMA RAJU BUDDHARAJUNon-Executive - Independent DirectorMember2014-08-122025-03-31Audit Committee02267273SUNNY SHARMANon-Executive - Non Independent DirectorMember2021-08-11Audit Committee00007995ABHINNA SUNDAR MOHANTYNon-Executive - Independent DirectorMember2019-07-11Nomination and remuneration committee03630668SEETHARAMA RAJU BUDDHARAJUNon-Executive - Independent DirectorChairperson2014-08-122025-03-31Nomination and remuneration committee00212589DIGANT MAHESH PARIKHNon-Executive - Independent DirectorMember2018-03-14Nomination and remuneration committee02267273SUNNY SHARMANon-Executive - Non Independent DirectorMember2021-08-11Nomination and remuneration committee00007995ABHINNA SUNDAR MOHANTYNon-Executive - Independent DirectorMember2019-07-11Stakeholders Relationship Committee03630668SEETHARAMA RAJU BUDDHARAJUNon-Executive - Independent DirectorChairperson2014-08-122025-03-31Stakeholders Relationship Committee08338573VARDDHMAN VIKRAMADITYA JAINExecutive DirectorMember2019-01-24Stakeholders Relationship Committee00212589DIGANT MAHESH PARIKHNon-Executive - Independent DirectorMember2018-03-14Stakeholders Relationship Committee00007995ABHINNA SUNDAR MOHANTYNon-Executive - Independent DirectorMember2019-07-11Risk Management Committee08338573VARDDHMAN VIKRAMADITYA JAINExecutive DirectorChairperson2019-01-24Risk Management Committee03630668SEETHARAMA RAJU BUDDHARAJUNon-Executive - Independent DirectorMember2014-10-312025-03-31Risk Management Committee02640342JITENDRA SHARMAChief Financial OfficerMember2014-10-31 Mr. Jitendra Sharma is a Non-Director member in Risk Management Committee Corporate Social Responsibility Committee08338573VARDDHMAN VIKRAMADITYA JAINExecutive DirectorChairperson2019-01-24Corporate Social Responsibility Committee00021023SANDRA SALDANHAExecutive DirectorMember2014-10-31Corporate Social Responsibility Committee03630668SEETHARAMA RAJU BUDDHARAJUNon-Executive - Independent DirectorMember2014-10-312025-03-312024-11-12true8842025-02-1190true884Audit Committee2024-11-12true4430Audit Committee2025-02-1190true4430Stakeholders Relationship Committee2024-11-12true4430Stakeholders Relationship Committee2025-02-1190true4430Nomination and remuneration committee2025-02-11true4430Risk Management Committee2025-02-11true2211Corporate Social Responsibility Committee2025-02-11true3310truetruetruetrueYestruetruetrueThe compliance report on Corporate Governance submitted for the previous quarter has been placed before the Board of Directors at its meeting held on February 11, 2025 and there are no comments/ observations/ advice of the Board of Directors in this regard. This report for the relevant quarter will be placed before the Board of Directors in its next meeting.Harshavardhan PanigrahiCompany Secretary and Compliance OfficerYeshttps://www.marksanspharma.com/company-profile.htmlYeshttps://www.marksanspharma.com/pdf/moa-aoa.pdfYeshttps://www.marksanspharma.com/board-of-directors.htmlYeshttps://www.marksanspharma.com/pdf/Code-of-Conduct.pdfYeshttps://www.marksanspharma.com/composition-of-board-and-committees.htmlYeshttps://www.marksanspharma.com/pdf/Code-of-Conduct.pdfYeshttps://www.marksanspharma.com/pdf/whistle-blower-policy.pdfYeshttps://www.marksanspharma.com/pdf/nomination-and-remuneration-policy.pdfYeshttps://www.marksanspharma.com/pdf/Policy-on-materiality-of-related-party-transactions-and-on-dealing-with-related-party-transactions.pdfYeshttps://www.marksanspharma.com/pdf/policy-on-material-subsidiary.pdfYeshttps://www.marksanspharma.com/pdf/familiarisation-programme-for-independent-directors-2024-25.pdfYeshttps://www.marksanspharma.com/investor-contact.htmlYeshttps://www.marksanspharma.com/investor-contact.htmlYeshttps://www.marksanspharma.com/quarterly-results.htmlYeshttps://www.marksanspharma.com/shareholding-pattern.htmlNAYeshttps://www.marksanspharma.com/earnings-call-transcripts.htmlYeshttps://www.marksanspharma.com/earnings-call-transcripts.htmlNAYeshttps://www.marksanspharma.com/newspaper-advertisement.htmlYeshttps://www.marksanspharma.com/corporate-announcements.htmlYeshttps://www.marksanspharma.com/subsidiary-accounts.htmlYeshttps://www.marksanspharma.com/others-disclosures.htmlYeshttps://www.marksanspharma.com/pdf/determining-materiality-for-disclosures.pdfYeshttps://www.marksanspharma.com/materiality-of-information.htmlYeshttps://www.marksanspharma.com/corporate-announcements.htmlYeshttps://www.marksanspharma.com/corporate-announcements.htmlYeshttps://www.marksanspharma.com/pdf/dividend-distribution-policy.pdfYeshttps://www.marksanspharma.com/pdf/annual-report/marksans-annual-report-mgt-2023-24.pdfNAYeshttps://www.marksanspharma.com/Yeshttps://www.marksanspharma.com/YesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesNAYesYesYesNAYesYesYesYesYesYesNAYesYesYesNANAWith respect to Point No. 32, sale and purchase transactions of finished goods to/from Time Cap Laboratories Inc, a wholly owned subsidiary of the Company for the year ended March 31, 2025 will be considered as material within the meaning of Regulation 23(1) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. However, Time Cap Laboratories Inc being a wholly owned subsidiary, sub-regulations 2, 3 and 4 of Regulation 23 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 shall not apply to the above transactions. The transactions are in the ordinary course of business on arm's length basis and repetitive in nature.Harshavardhan PanigrahiCompany Secretary and Compliance OfficerYesHarshavardhan PanigrahiCompany Secretary and Compliance OfficerfalseHarshavardhan PanigrahiCompany Secretary and Compliance OfficerMumbai2025-04-1100000Income Tax Department2015-08-10Revenue has filed appeal in the High Court which is ongoing.Revenue has filed appeal in the High Court which is ongoing.Income Tax Department2017-12-18Written submisison in response to hearing notice dated 19-11-2024 is submitted on 16-12-2024. Awaiting for order from Hon'ble CIT (A)Written submisison in response to hearing notice dated 19-11-2024 is submitted on 16-12-2024. Awaiting for order from Hon'ble CIT (A)